Early prediction of response to tyrosine kinase inhibitors by quantification of EGFR mutations in plasma of non-small cell lung cancer patients.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 8079-8079
Author(s):  
Antonio Marchetti ◽  
John F. Palma ◽  
Lara Felicioni ◽  
Tommaso Martino De Pas ◽  
Rita Chiari ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Kinase Inhibitors ◽  
Small Cell ◽  
Egfr Mutations ◽  
Early Prediction ◽  
Small Cell Lung ◽  
Prediction Of Response ◽  
Lung Cancer Patients

scholarly journals BRCA1, LMO4, and CtIP mRNA Expression in Erlotinib-Treated Non–Small-Cell Lung Cancer Patients with EGFR Mutations

2013 ◽  
Vol 8 (3) ◽  
pp. 295-300 ◽  
Author(s):  
Niki Karachaliou ◽  
Carlota Costa ◽  
Ana Gimenez-Capitan ◽  
Miguel Angel Molina-Vila ◽  
Jordi Bertran-Alamillo ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Mrna Expression ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Egfr Mutations ◽  
Small Cell Lung ◽  
Lung Cancer Patients

scholarly journals Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors

2008 ◽  
Vol 19 (9) ◽  
pp. 1605-1612 ◽  
Author(s):  
P.A. Zucali ◽  
M.G. Ruiz ◽  
E. Giovannetti ◽  
A. Destro ◽  
M. Varella-Garcia ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Kinase Inhibitors ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Egfr Tyrosine Kinase Inhibitors
Sign in / Sign up

Export Citation Format

Share Document